Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology
CONCLUSION: The use of G-CSF for primary prophylaxis in chemotherapy for colorectal cancer is inappropriate.PMID:38578596 | DOI:10.1007/s10147-024-02502-6
Source: Clinical Breast Cancer - Category: Cancer & Oncology Authors: Mamoru Ito Yuta Okumura Kenta Nio Eishi Baba Yukinori Ozaki Hiroshi Nishio Eiki Ichihara Yuji Miura Makoto Endo Shingo Yano Dai Maruyama Tetsuhiro Yoshinami Nobuyuki Susumu Munetaka Takekuma Takashi Motohashi Nobuaki Ochi Toshio Kubo Keita Uchino Takahiro Source Type: research
More News: Brain | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Colorectal Cancer | Databases & Libraries | Esophagus Cancer | Gastric (Stomach) Cancer | Gastroenterology | Japan Health | Neurology | Pancreas | Pancreatic Cancer